IRIS
DE LUCA, GIACOMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 60
NA - Nord America 14
AS - Asia 9
AF - Africa 3
Totale 86
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 38
FR - Francia 13
US - Stati Uniti d'America 10
CN - Cina 4
ML - Mali 3
MX - Messico 3
GB - Regno Unito 2
RU - Federazione Russa 2
CA - Canada 1
DE - Germania 1
IE - Irlanda 1
IN - India 1
JP - Giappone 1
KR - Corea 1
NL - Olanda 1
NO - Norvegia 1
SE - Svezia 1
SG - Singapore 1
TR - Turchia 1
Totale 86
Salva come PNG Salva come JPEG
Città #
Milan 20
Vaprio d'Adda 5
Ancona 4
Ashburn 4
Osimo 3
Zhengzhou 3
Dalmine 2
Guadalajara 2
Rome 2
Bracke 1
Busto Arsizio 1
Columbus 1
Coram 1
Dublin 1
Dunoon 1
Eindhoven 1
Florence 1
Frankfurt am Main 1
Hampstead 1
Henrico 1
Konyaalti 1
London 1
Los Angeles 1
Nagoya 1
Nepean 1
Oslo 1
Pune 1
Querétaro City 1
Seongnam-si 1
Shanghai 1
West Jordan 1
Totale 67
Salva come PNG Salva come JPEG
Nome #
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review, file 872defbc-9a7e-44a9-ae03-577c5245d11c 14
Exercise Stress Test Late after Arrhythmic versus Nonarrhythmic Presentation of Myocarditis, file 799a269a-d8bb-4437-855e-39e7db9f37ce 10
Generalized morphea after COVID-19 vaccines: a case series, file 98826ff8-44c1-4ed7-96c3-ac086214f7be 10
Open questions on the management of targeted therapies for the treatment of systemic sclerosis-interstitial lung disease: results of a EUSTAR survey based on a systemic literature review, file 665d144e-9f35-4ca2-b24f-0757883ce1b3 7
Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities, file 10fbee28-4784-4465-b608-d3547e3c1e68 6
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature, file d9947de7-582b-4d18-9b01-2df9b009fd44 6
Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group, file 386ce159-c260-419c-93a1-5b24e556d2e8 4
Serum organ-specific anti-heart and anti-intercalated disk autoantibodies as new autoimmune markers of cardiac involvement in systemic sclerosis: Frequency, clinical and prognostic correlates, file 5a872834-604e-4392-ada7-ee067a7bdf45 4
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey, file d68e35f8-bbd8-46d5-8a55-06a947c8a3ea 3
Does the impact of COVID-19 on patients with systemic sclerosis change over time?, file eec3d99d-d037-48cf-81d2-69f071f11043 3
Exercise Stress Test Late after Arrhythmic versus Nonarrhythmic Presentation of Myocarditis, file 16a803e1-652d-48af-8c61-6da1700b466a 2
Corrigendum to “Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience” [Autoimmunity Reviews, Volume 20, Issue 12, December 2021, 102981](S1568997221002615)(10.1016/j.autrev.2021.102981), file 2756be93-4500-4041-a334-95eb4a9bb9de 1
Clinical profiling and outcomes of viral myocarditis manifesting with ventricular arrhythmias, file 346fe3b3-861e-40db-920f-b83bd8cd2fa1 1
Myocarditis as a manifestation of Erdheim–Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapy, file 3589b16c-39dc-46c9-a301-1a150ac4af18 1
Multimodal Detection and Targeting of Biopsy-Proven Myocardial Inflammation in Genetic Cardiomyopathies: A Pilot Report, file 5ec70d5c-4544-412b-8444-4e2b2c23b5fc 1
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of scleroderma spectrum, file 84f6d02e-5e1f-4ac2-aff7-6ba95c5b4632 1
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology, file b80de664-2394-4326-a27d-99d1e0750fb5 1
Treatment of Dilated Cardiomyopathy With Interleukin-1 Inhibition, file e0c35a4c-9910-5883-e053-d805fe0ac580 1
Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience, file e0c35a4c-9d97-5883-e053-d805fe0ac580 1
Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli, file e0c35a4c-a8c9-5883-e053-d805fe0ac580 1
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19, file e0c35a4c-cb3e-5883-e053-d805fe0ac580 1
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation, file e0c35a4c-e0dc-5883-e053-d805fe0ac580 1
Patient-reported outcome instruments in clinical trials of systemic sclerosis, file e0c35a4c-eb7b-5883-e053-d805fe0ac580 1
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers, file e0c35a4c-ecf7-5883-e053-d805fe0ac580 1
Drug retention rates of biological agents in adult onset Still's disease, file e0c35a4c-ecf9-5883-e053-d805fe0ac580 1
Efficacy and Safety of Methotrexate for the Treatment of Autoimmune Virus-Negative Myocarditis: A Case Series, file e0c35a4c-ed75-5883-e053-d805fe0ac580 1
Tocilizumab for the Treatment of Myocardial Inflammation Shown by Cardiac Magnetic Resonance: Report of Two Cases and Rationale for Its Therapeutic Use, file e0c35a4c-f71c-5883-e053-d805fe0ac580 1
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies, file e0c35a4d-0d2a-5883-e053-d805fe0ac580 1
Totale 86
Salva come PNG Salva come JPEG
Categoria #
all - tutte 438
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 438
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 0 0 0 2 0
2020/20212 0 0 0 0 0 0 0 1 0 0 0 1
2021/20224 0 0 4 0 0 0 0 0 0 0 0 0
2022/202337 0 0 0 0 2 1 9 12 3 5 5 0
2023/202441 0 0 0 5 3 2 3 7 9 12 0 0
Totale 86